Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-21-017272

SVP, Business Development sold 20,465 shares at an average $18.28 ($374,017)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Birznieks Gunther SVP, Business Development 2021-03-01 Sale −3,845 $18.66 $71,744 188,328 D: show line 1 in the form
Birznieks Gunther SVP, Business Development 2021-03-02 Sale −16,620 $18.19 $302,273 171,708 D: show line 2 in the form
Open-market sales · 20,465 sh · avg $18.28 · $374,017
Loading xslF345X03/doc4.xml…